Transform Your Life with Tirzepatide

Our Injectable tirzepatide and additive is a compounded GLP-1 and GIP receptor agonist that is injected in once weekly doses. In clinical trials tirzepatide showed a greater percentage weight loss in obese patients that did not have diabetes and when compared head to head with semaglutide, it has been shown that patients taking tirzepatide show a higher percentage weight loss over the same time period. Patients will receive a one month supply of both the medication and supplies including syringes at a time and can change doses at no additional cost if directed by their physician. Our primary additive is B12, note that compounded medications such as this are not FDA approved, and this not the same as Mounjaro.